Buda Juice, Inc. is a US-listed company in the beverages industry. Its financial year ends in December.
Stock price today
Loading chart…
Third-party market data · may be delayed
Model estimate per share
~$4.3
Price-to-earnings vs peers
Base case. Range ~$3.9–$5.2. Earnings per share times peers' typical (harmonic-mean) price-to-earnings.
Price vs value
No Buy/Hold/Sell rating is issued: limited reported history: available models are shown without a Buy/Hold/Sell rating.
Buda Juice, Inc. valuation: adjust assumptions and compare models →
Who’s trading
What company insiders, investment funds and members of Congress have been doing with the stock, from their own filings.
- Funds9 adding, 2 cuttingOf 1 active managers that changed their stake, 0 added; quarter to June 30, 2026Fund buyers and sellers
The Fundamentalytics view
Current signal Results well short of expectations: Reported earnings per share missed the analysts' consensus estimate by 20% in the quarter to 2026-06-30.
Assembled from SEC-filed figures — the full workings are on this page and in our methodology. Observations, not recommendations.
Highlights
How we pick theseStrengths
Nothing in Buda Juice, Inc.'s latest figures clears our strength thresholds.
Things to watch
- Volatile shares. Over the past year the shares showed annualised volatility of 71% and a beta of -0.3 against the S&P 500.
- Estimates being cut. Analysts' consensus for next year's earnings per share has fallen 44.3% over 90 days.
Latest results: FY2026 Q2
- Earnings per share
- $0.04 against an average estimate of $0.05: missed by 20.0%
- Revenue
- $5m, up 26.4% on a year earlier
- Next report
- November 12, 2026
Price chart
- 1 day+5.4%
- 1 week+8.6%
- 1 month-6.4%
Loading chart…
Third-party market data · may be delayed
At a glance
Earnings
- Last results
- May 15, 2026
News & updates
Company announcements, filed results and changes that matter to shareholders.
No recent updates are available for BUDA from the sources we follow. See filings →
Valuation models
We value Buda Juice, Inc. as an operating company, with every model that fits that kind of business. Cost of equity 7.4%: the 10-year Treasury yield (4.9%) plus a beta of 0.54 times a 4.5% equity risk premium.
| Model | Value per share | In the combined value? |
|---|---|---|
| Price-to-earnings vs peers Earnings per share times peers' typical (harmonic-mean) price-to-earnings. | ~$4.3 ~$3.9–$5.2 | Primary model, counts double |
| Residual income Book value plus the present value of returns above the cost of equity, fading over ten years. | — | Does not apply: book value or earnings not available |
| Justified price-to-book Book value times (return on equity - growth) / (cost of equity - growth): steady-state returns. | — | Does not apply: return on equity is not positive |
| Revenue-to-maturity model Revenue grown to maturity with the cash margin moving to the industry's; for companies not yet profitable. | — | Does not apply: revenue and margins don't support a positive value |
| Price-to-sales vs peers Sales per share times peers' typical price-to-sales; used only when earnings are negative. | ~$0.4 ~$0.5–$3.0 | Left out: out of range vs price (0.06x) |
| Combined value Weighted average of the models that apply: the primary model (price-to-earnings vs peers) counts double. Models more than 5x or less than 0.2x the share price, or more than 3x away from the other models' median, are left out. | ~$4.3 ~$3.9–$5.2 | 1 model |
Different models fail in different ways, so where several apply we average them rather than trust one. Peer-based models compare Buda Juice, Inc. with Beverages in our coverage, using third-party market data. Model values are estimates under stated assumptions, updated as new filings arrive; not price targets or investment advice. How each model works.
Moat
Not assessed: fewer than five years of comparable figures in the filings. AI disruption exposure for this industry: Low.
Forecasts and guidance
Next results: November 12, 2026, after the close. Analysts expect revenue of $5m for the quarter.
Analysts' consensus
| Fiscal year | EPS | Growth | Revenue | Growth |
|---|---|---|---|---|
| Current | $0.13 | −35% | $17m | — |
| Next | $0.20 | +50% | $21m | +22% |
Next year's EPS estimate has moved −44.3% in 90 days, across 2 analysts.
How the EPS forecast has moved
The consensus EPS forecast for the current fiscal year is −45.8% on 90 days ago. In the last 30 days, 0 analysts raised Buda Juice, Inc.'s forecast and 1 cut it.
Average of analysts' published estimates (third-party data).
View chart data
| Period | Current fiscal year | Next fiscal year |
|---|---|---|
| 90 days ago | $0.24 | $0.35 |
| 60 days ago | $0.24 | $0.35 |
| 30 days ago | $0.20 | $0.35 |
| 7 days ago | $0.15 | $0.25 |
| Now | $0.13 | $0.20 |
Earnings against estimates
| Quarter to | Estimate | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | $0.05 | $0.04 | −20.0% |
| Mar 2026 | $0.03 | $0.03 | 0.0% |
Adjusted EPS as companies report it, against the average analyst estimate.
Positioning
- Short interest
- 0.1% of tradable shares
- Days to cover
- 0.49 at average volume
- Short interest, 1 month
- +34% to October 15, 2026
- Held by institutions
- 13% of shares
- Held by insiders
- 74.0% of shares
- Employees
- 39 full time
Share-price performance
Market data may be delayedPrice behaviour
- 52-week range
- Not enough history
- From 52-week high
- —
- vs 50-day average
- −5.6%
- vs 200-day average
- −17.8%
- Volatility (1 year)
- 71%
- Beta vs S&P 500
- -0.28
Share price after results
- Next day
- 1 up, 0 down typical move ±2.6%
- After a week
- 0 up, 1 down typical move ±3.3%
- After a month
- 0 up, 1 down typical move ±13.6%
| Results released | Next day | S&P 500 next day | 5 days | 21 days |
|---|---|---|---|---|
| May 15, 2026 | +2.6% | −1.3% | −3.3% | −13.6% |
Fundamentals
Where the money goes
Each dollar Buda Juice took in during FY2025, followed through to profit: what it cost to make, what went on running the business, and what was left after tax.
| Revenue | $12.6M | |
|---|---|---|
| Other income | $84,000 | 0.7% of revenue |
| Cost of revenue | $7M | 55.4% of revenue |
| Gross profit | $5.6M | 44.6% of revenue |
| Selling, general and admin | $1.7M | 13.3% of revenue |
| Other operating costs | $509,000 | 4.0% of revenue |
| Operating income | $3.4M | 27.4% of revenue |
| Net income | $3.5M | 28.0% of revenue |
Financial statements
| Fiscal year | 2024 Dec 2024 | 2025 Dec 2025 |
|---|---|---|
| Income | ||
| Revenue | 11 | 13 |
| Gross profit | 5 | 6 |
| EBITDA | 4 | 4 |
| Operating income | 3 | 3 |
| Net income | 4 | 4 |
| Diluted EPS | $0.20 | $0.20 |
| Growth (year on year) | ||
| Revenue | — | +11.8% |
| EBITDA | — | +0.1% |
| Operating income | — | +1.1% |
| Net income | — | −1.1% |
| Diluted EPS | — | 0.0% |
| Margins | ||
| Gross margin | 46.2% | 44.6% |
| EBITDA margin | 32.7% | 29.2% |
| Operating margin | 30.3% | 27.4% |
| Net margin | 31.7% | 28.0% |
| Free-cash-flow margin | 29.2% | 23.0% |
| Cash flow | ||
| Cash from operations | 4 | 3 |
| Capital spending | 1 | 0 |
| Free cash flow | 3 | 3 |
| Balance sheet | ||
| Cash | 2 | 2 |
| Total debt | 0 | 1 |
| Net debt (negative = net cash) | −2 | −1 |
| Diluted shares | — | 14m |
| Quarter | 2025 Q1 Mar 2025 | 2025 Q2 Jun 2025 | 2026 Q1 Mar 2026 | 2026 Q2 Jun 2026 |
|---|---|---|---|---|
| Income | ||||
| Revenue | 2,980 | 3,567 | 3,508 | 4,508 |
| Gross profit | 1,338 | 1,667 | 1,386 | 1,651 |
| EBITDA | 890 | 1,214 | 650 | 506 |
| Operating income | 803 | 1,144 | 593 | 444 |
| Net income | 807 | 1,170 | 388 | 470 |
| Diluted EPS | — | — | $0.03 | $0.04 |
| Growth (year on year) | ||||
| Revenue | — | — | +17.7% | +26.4% |
| EBITDA | — | — | −27.0% | −58.3% |
| Operating income | — | — | −26.2% | −61.2% |
| Net income | — | — | −51.9% | −59.8% |
| Margins | ||||
| Gross margin | 44.9% | 46.7% | 39.5% | 36.6% |
| EBITDA margin | 29.9% | 34.0% | 18.5% | 11.2% |
| Operating margin | 26.9% | 32.1% | 16.9% | 9.8% |
| Net margin | 27.1% | 32.8% | 11.1% | 10.4% |
| Free-cash-flow margin | 25.7% | — | 31.0% | −5.5% |
| Cash flow | ||||
| Cash from operations | 904 | 929 | 1,305 | −365 |
| Capital spending | 139 | — | 218 | −118 |
| Free cash flow | 765 | — | 1,087 | −247 |
| Stock-based pay | — | — | — | 213 |
| Free cash flow after stock pay | — | — | — | −460 |
Financial health
- Short-term assets cover short-term liabilities $22m of assets due within a year against $1m of liabilities due within a year.
- Short-term assets cover long-term liabilities $22m short-term assets against $755,000 of longer-dated liabilities.
- More cash than debt $19m of cash against $755,000 of debt.
- Debt below 40% of shareholders' equity Debt is 3% of equity.
- Debt burden no higher than five years ago Five-year comparison not available. Not assessable.
- A year's operating cash flow covers at least 20% of debt Cash flow or debt not reported. Not assessable.
- Operating profit covers interest at least five times over No material interest expense reported.
Where the revenue comes from
| Line of business | Revenue | Share | YoY |
|---|---|---|---|
| Products | $12.6M | 100.0% | ▲ 11.8% |
| Branded (part of Products) | $7M | 55.7% | ▼ 9.0% |
| Private Label Other (part of Products) | $5.6M | 44.3% | ▲ 57.2% |
From Buda Juice, Inc.'s 10-K filed March 26, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.
Who owns it
Funds buying and selling- Reported value
- $3.3M
- Institutions reporting
- 13
- Shares held vs prior quarter
- ▼ 4.7%
- Positions opened / closed
- 6 / 1
| Manager | Value | Shares | Share of 13F value | Shares QoQ |
|---|---|---|---|---|
| Bard Associates Inc | $2.5M | 293K | 75.5% | ▼ 0.1% |
| Vanguard Capital Management LLC | $317,176 | 37K | 9.6% | ▲ 11.7% |
| Geode Capital Management, LLC | $198,137 | 23K | 6.0% | 0.0% |
| Vanguard Fiduciary Trust Co | $139,581 | 16K | 4.2% | 0.0% |
| Blackrock, Inc. | $102,341 | 12K | 3.1% | ▲ 37.8% |
| Soa Wealth Advisors, Llc. | $28,347 | 3K | 0.9% | New |
| Osaic Holdings, Inc. | $10,212 | 1K | 0.3% | New |
| UBS Group AG | $5,991 | 1K | 0.2% | New |
| Tower Research Capital LLC (TRC) | $5,055 | 1K | 0.2% | ▲ 74.2% |
| Arax Advisory Partners | $1,702 | 0K | 0.1% | New |
| Morgan Stanley | $945 | 0K | 0.0% | 0.0% |
| Barclays PLC | $111 | 0K | 0.0% | New |
From Form 13F filings with the SEC ( quarterly data sets), as reported by each manager for June 30, 2026 and filed up to 45 days later. 13F reports cover long US-listed positions of managers above $100M only, so this is not Buda Juice, Inc.'s complete shareholder register. Values are as reported by the filers .
Insider trading activity
Full insider history and chartFrom insiders' Form 4 filings with the SEC. Excludes awards, option exercises and shares withheld for tax. "Pre-set plan" means the filing marks the trade as made under a Rule 10b5-1 plan. See every insider trade since five years ago, on a price chart.
Earnings dates and SEC filings
Results announcements
- May 15, 2026
Recent SEC filings
- 10-Q Quarterly report
- 8-K Current report
- 10-Q Quarterly report
- 10-K Annual report
- 8-K Current report
- 8-K Current report
- S-1 S-1
Data status
| Data | Last updated | Source |
|---|---|---|
| Share price | Exchange closing prices | |
| Financial statements | SEC 10-K and 10-Q filings | |
| News and updates | Company releases and SEC 8-K filings | |
| Analyst estimates | Aggregated analyst estimates | |
| Valuation and scores | Our models, from the filed figures |
Buda Juice, Inc. in brief
- What does Buda Juice, Inc. do?
- Buda Juice, Inc. is a US-listed company in the beverages industry. Its financial year ends in December.
- What is Buda Juice, Inc.'s stock ticker?
- Buda Juice, Inc. trades under the ticker BUDA on NYSE. This page brings together its financial statements, valuation models, ownership and recent company updates.
- Who are Buda Juice, Inc.'s largest institutional shareholders?
- By value reported in 13F filings for June 30, 2026, the largest reported holders are Bard Associates Inc, Vanguard Capital Management LLC and Geode Capital Management, LLC. 13F reports cover long US-listed positions of managers above $100M, filed up to 45 days after quarter end.
- How much debt does Buda Juice, Inc. have?
- Buda Juice, Inc.'s debt-to-equity ratio is 3.5%, from its latest balance sheet. The financial health section below sets out its other solvency checks.
- When is Buda Juice, Inc.'s next earnings date?
- Around November 12, 2026, estimated from the spacing of its past results announcements (8-K filings). That is an estimate, not a confirmed date — Buda Juice, Inc. announces its own schedule.
Follow research on Buda Juice, Inc.
New research on the companies we cover arrives in the weekly email. Free, one email a week.